Prokidney Corp share price logo

Prokidney Corp Share Price

NASDAQ: PROK

Small Cap

$2.48

-0.50

(-16.95%)

as on

Prokidney Corp Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.37
    $3.05
    downward going graph

    4.44%

    Downside

    22.98%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.46
    $7.13
    downward going graph

    81.44%

    Downside

    187.50%

    Upside

    downward going graph

Prokidney Corp share price movements today

Previous Close
$2.98
Open
$3.00
Volume
10.7M
Day's Low - High
$2.37 - $3.05
52 Week Low - High
$0.46 - $7.13

Prokidney Corp Historical Returns

1 Month Return
+ 25.74 %
3 Month Return
+ 255.48 %
1 Year Return
+ 24.69 %
3 Year Return
-69.34 %
5 Year Return
0 %

Prokidney Corp Stock Fundamentals & Key Indicators

Check Prokidney Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-0.5267

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-170.2M

Revenue (TTM)

527.0K

Profit Margin

0.00%

Return On Equity TTM

10948500.00%

Prokidney Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Prokidney Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Prokidney Corp image
Prokidney Corp
BUY$1.8BNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B280.5%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$37.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.2B54.04%28.0831.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Prokidney Corp Stock including INR - Dollar returns

The Prokidney Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Prokidney Corp investment value today

Current value as on today

₹1,08,905

Returns

₹8,905

(+8.9%)

Returns from Prokidney Corp Stock

₹3,766 (+3.77%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Prokidney Corp Stock

Based on 12 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 12 analysts, 66.67% of analysts recommend a 'BUY' rating for Prokidney Corp. Average target price of $5.83

Prokidney Corp Share Price Target

Get share price movements and forecasts by analysts on Prokidney Corp.

What analysts predicted

57.46%UPSIDE

Target Price

$5.83

Current Price

$2.48

Analyzed by

12 Analysts

Target

$5.83

Prokidney Corp target price $5.83, a slight upside of 57.46% compared to current price of $2.48. According to 12 analysts rating.

Prokidney Corp Stock's Interest Amongst Investors

Search interest for Prokidney Corp Stock has decreased by -69% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-69% versus previous 30 day period

Prokidney Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
4
-
-
-
0
0
0
Gross Profit
0
0
0
3
0
0
-1
0
0
0
Operating Income
-40
-39
-46
-24
-40
-43
-48
-51
-41
-39
EBITDA
-34
-32
-40
-17
-34
-37
-41
-45
-35
-34
Interest Expense
0
0
0
0
0
0
0
0
-
0
Depreciation
0
0
1
1
1
1
1
1
1
1
Income Before Tax
-35
-33
-41
-18
-35
-38
-43
-46
-37
-36
Income Tax Expense
1
0
0
2
0
0
-2
1
0
0
Net Income
-9
-9
-10
-5
-9
-12
-17
-21
-16
-16
Net Profit Margin
0.00%
0.00%
0.00%
-126.86%
0.00%
0.00%
0.00%
-27997.37%
-7275.65%
-7489.59%

Prokidney Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
0
Gross Profit
-
-1
-3
-3
0
Operating Income
-27
-55
-153
-151
-183
EBITDA
-26
-53
-143
-147
-158
Interest Expense
0
0
0
0
0
Depreciation
0
1
3
3
5
Income Before Tax
-26
-55
-147
-129
-163
Income Tax Expense
0
0
0
5
0
Net Income
-26
-55
-108
-35
-61
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-80507.89%

Prokidney Corp Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-34
-41
-21
-35
-38
-41
-48
-16
-70
Operating Cash Flow
-14
-23
-25
-34
-38
-29
-24
-29
-60
Investing Cash Flow
-13
-28
-95
58
28
-81
15
28
46
Financing Cash Flow
0
0
-9
0
139
4
0
0
0
Change in Cash
-28
-52
-130
23
130
-106
-8
-1
84

Prokidney Corp Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-26
-55
-148
-135
-163
Operating Cash Flow
-25
-50
-77
-90
-126
Investing Cash Flow
-5
-5
-1
-329
20
Financing Cash Flow
19
71
548
-9
144
Change in Cash
-10
15
469
-429
38

Global Institutional Holdings in Prokidney Corp

Funds
Holdings
Suvretta Capital Management, LLC
9.25%
Morgan Stanley - Brokerage Accounts
7.75%
BlackRock Inc
5.07%
Vanguard Group Inc
3.91%
Geode Capital Management, LLC
1.74%
See all

Prokidney Corp News & Key Events

  • img

    Today's Timeline - 27 August

    Wed, 05:00 PM

    -

    ProKidney announces participation in Citi and Morgan Stanley healthcare conferences in September 2025.

Insights on Prokidney Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, PROK stock has moved up by 194.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 72.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 199.0%

About Prokidney Corp

prokidney (nasdaq: prok), a pioneer in the treatment of ckd through innovations in cellular therapy, was founded in 2015 after a decade of research. prokidney’s lead product candidate, react™ (renal autologous cell therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of ckd, but in some cases potentially drive meaningful improvement in kidney function. late-stage ckd, stage 3b - 4, is a key target for react™ therapy. react™ has received regenerative medicine advanced therapy (rmat) designation, as well as fda and ema guidance, supporting its ongoing phase 3 clinical program, which launched in january 2022. for more information, visit www.prokidney.com.
OrganisationProkidney Corp
Headquarters2000 Frontis Plaza Blvd., Winston-Salem, NC, United States, 27103
IndustryFinancial
CEODr. Bruce Culleton M.D.
E-voting on sharesClick here to vote

Key Management of Prokidney Corp

Name

Title

Ms. Anu Biswas

Senior VP of Manufacturing & Operations

Dr. Darin J. Weber Ph.D.

Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access

Mr. Nikhil L. Pereira-Kamath

Chief Business Officer

Ms. Carla Poulson

Chief People Officer

Dr. Joseph M. Stavas M.D., M.P.H.

SVP of Clinical Affairs

Dr. Bruce Culleton M.D.

CEO & Director

Dr. Ulrich Ernst Ph.D.

EVP of Science and Technology

Mr. Todd C. Girolamo Esq., J.D., M.B.A.

Chief Legal Officer & Secretary

Mr. James Coulston CPA

Chief Financial Officer

Mr. Richard Williams

Chief Information Officer

FAQs

What is Prokidney Corp share price today?

Prokidney Corp share price today is $2.48 as on at the close of the market. Prokidney Corp share today touched a day high of $3.05 and a low of $2.37.

What is the 52 week high and 52 week low for Prokidney Corp share?

Prokidney Corp share touched a 52 week high of $7.13 on and a 52 week low of $0.46 on . Prokidney Corp stock price today i.e. is closed at $2.48,which is 65.22% down from its 52 week high and 438.78% up from its 52 week low.

What is Prokidney Corp's market capitalisation today?

Prokidney Corp market capitalisation is $0.00T as on .

How to invest in Prokidney Corp Stock (PROK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Prokidney Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Prokidney Corp Shares that will get you 0.6048 shares as per Prokidney Corp share price of $2.48 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Prokidney Corp Stock (PROK) from India?

Indian investors can start investing in Prokidney Corp (PROK) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Prokidney Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Prokidney Corp share’s latest price of $2.48 as on September 13, 2025 at 1:29 am IST, you will get 4.0323 shares of Prokidney Corp. Learn more about fractional shares .